Exactech sees $67.3M in Q2 revenue; extremities revenue jumps 19% — 13 highlights

Exactech reported its second quarter and first half of 2017 financial results.

Advertisement

Here are second quarter highlights:

 

1. The company saw a 2 percent jump in second quarter revenue, from $66.1 million in the second quarter of 2016 to $67.3 million.

 

2. Exactech reported domestic revenue increased to $45.7 million in the second quarter of 2017, compared to the same period the year prior.

 

3. The company’s diluted earnings per share were $0.33 based on $4.8 million net income in the second quarter of 2017.

 

4. The extremities segment revenue hit $29.5 million in the second quarter of 2017, reflecting a 19 percent increase from the same period in 2016.

 

5. Knee segment revenue proved flat at $19.6 million in the second quarter of 2017.

 

6. Exactech’s hip segment revenue fell 8 percent to $11.5 million, compared to the second quarter of 2016.

 

7. The company’s ‘other’ segment, inclusive of biologics and spine, decreased 27 percent to $6.7 million, compared to the second quarter of 2016.

 

Here are first half of 2017 highlights:

 

8. In the first half of 2017, Exactech reported $136.8 million in revenue, a 4 percent increase over the same period in 2016.

 

9. Net income rose 7 percent to $9.4 million in the first half of 2017, compared to the same period the year prior.

 

10. Extremities segment revenue jumped to $59.4 million, a 20 percent increase over the same period the year prior.

 

11. Knee segment revenue increased 1 percent over the first half of 2016, to $39.7 million.

 

12. Hip segment revenue fell 1 percent to $23.6 million, compared to the first half of 2016.

 

13. ‘Other’ segment revenue, inclusive of biologics and spine, decreased 24 percent to $14.1 million, compared to the same period the year prior.

 

The company updated its 2017 revenue guidance to between $267 million and $271 million.

 

More articles on devices:
No fusion, no problem — How coflex is changing the lumbar spinal stenosis treatment field
Stryker reports 6.1% Q2 growth, installs 26 Mako systems: 7 things to know
NuVasive loses COO, CFO and promotes 3 executives amid organizational restructuring

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.